BD Oncomark™ Anti-Human CD79b FITC/Kappa PE/CD19 PerCP-Cy™5.5 335803

Reactivity: Human
Application: Flow cytometry
Regulatory Status: RUO (GMP)
RRID: AB_399978
Storage Buffer: Phosphate buffered saline with BSA and 0.1% sodium azide.
Description: Description CD79b, clone SN8 (3A2-2E7-1F5), is generated from the fusion of NS-1 myeloma cells with spleen cells from BALB/c mice immunized with an antigen prepared from the membrane of B-prolymphocytic leukemia (B-PLL) cells. Anti-Kappa, clone TB28-2, is derived from hybridization of mouse P3-X63-Ag8.653 myeloma cells with cells from CB6 (BC57b x BALB/c) mice immunized with human IgG-κ myeloma protein. CD19, clone SJ25C1, is derived from the hybridization of mouse Sp2/0 cells with spleen cells from BALB/c mice immunized with NALM1 + NALM16 cells. CD79b, clone SN8, reacts with the CD79b protein and the epitope lies on the extra domain of the peptide. CD79b is helpful in delineating signal transduction pathway activated via antibody receptors during different stages of B-cell differentiation. Anti-Kappa is specific for kappa light chains of human immunoglobulins. CD19 (SJ25C1) recognizes a 90-kilodalton (kd) antigen that is present on human B lymphocytes.
Preparation And Storage: Preparation And Storage Store vials at 2°C–8°C. Conjugated forms should not be frozen. Protect from exposure to light. Each reagent is stable until the expiration date shown on the bottle label when stored as directed.
Description : Clone : Isotype : EntrezGene ID
N/A : N/A : | IgG1, κ,IgG1, κ,IgG1, κ : N/A